Cargando…

Cutaneous bacteria induce immunosuppression

Detalles Bibliográficos
Autores principales:	Skabytska, Yuliya, Biedermann, Tilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741538/ https://www.ncbi.nlm.nih.gov/pubmed/26450905

Ejemplares similares

Regulation of T Cell Immunity in Atopic Dermatitis by Microbes: The Yin and Yang of Cutaneous Inflammation
por: Biedermann, Tilo, et al.
Publicado: (2015)

Inflammatory Cues Direct Skin-Resident Type 1 Innate Lymphoid Cells to Adopt a Psoriasis-Promoting Identity
por: Evers, Beatrix D.G., et al.
Publicado: (2023)

Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis
por: Arbiser, Jack L., et al.
Publicado: (2017)

Mechanisms of local immunosuppression in cutaneous melanoma
por: Polak, M E, et al.
Publicado: (2007)

Targeting CD38 alleviates tumor-induced immunosuppression
por: Tai, Yu-Tzu, et al.
Publicado: (2017)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

Immunosuppressive therapy in dermatology and PML
por: Sterry, Wolfram, et al.
Publicado: (2009)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Immunosuppression by viral N proteins
por: Chen, Jidang, et al.
Publicado: (2017)

The paradox of immunosuppressants and COVID-19
por: Cheng, Guang-Shing, et al.
Publicado: (2022)

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression
por: Mahdavi, Maryam, et al.
Publicado: (2020)

Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression
por: Tsutsumi, Yutaka, et al.
Publicado: (2021)

Cutaneous ulcer in an immunosuppressed patient with adult onset Still's disease: primary cutaneous histoplasmosis?()
por: Lise, Michelle Larissa Zini, et al.
Publicado: (2014)

Immunosuppression by hemorrhagic fever-causing viruses
por: Meyer, Bjoern, et al.
Publicado: (2015)

Endemic Diseases: Globalization, Urbanization, and Immunosuppression
por: Shikanai Yasuda, Maria Aparecida, et al.
Publicado: (2013)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Uniquely conserved immunosuppressive viral exoribonucleases
por: Meyer, Bjoern, et al.
Publicado: (2017)

Immunosuppressive arenaviral exoribonuclease
por: Meyer, Bjoern, et al.
Publicado: (2015)

More insights into the immunosuppressive potential of tumor exosomes
por: Huber, Veronica, et al.
Publicado: (2008)

Adding eltrombopag to immunosuppression: the importance of predicting outcome
por: Tichelli, André, et al.
Publicado: (2022)

Cutaneous Legionella longbeachae Infection in Immunosuppressed Woman, United Kingdom
por: Grimstead, Daniel, et al.
Publicado: (2015)

Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin
por: Costello, Collin M., et al.
Publicado: (2019)

Towards Steroid-Free Immunosuppression after Liver Transplantation
por: Zaydfudim, Victor M., et al.
Publicado: (2016)

Immunosuppression for COVID-19: repurposing medicines in a pandemic
por: Shivakumar, Senthuran, et al.
Publicado: (2020)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs
por: Isaacs, John D, et al.
Publicado: (2020)

A Need for Targeted Immunosuppression after Lung Transplantation
por: Bharat, Ankit
Publicado: (2019)

Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer
por: Jiang, Han, et al.
Publicado: (2022)

Liposuction and the Cutaneous Surgeon
por: Venkataram, Jayashree, et al.
Publicado: (2013)

Sub-Cutaneous Morphia
Publicado: (1874)

Cutaneous and Venereal Memoranda
Publicado: (1878)

Extensive, Multifocal Cutaneous Leishmaniasis Presenting with Varied Morphologies in an Immunosuppressed Patient
por: Watson, Ian T., et al.
Publicado: (2019)

Phialemoniopsis limonesiae sp. nov. causing cutaneous phaeohyphomycosis in an immunosuppressed woman
por: Alvarez Martinez, D., et al.
Publicado: (2021)

USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
por: Zhang, Qian, et al.
Publicado: (2022)

Anticoagulants and Immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
por: Turi, S, et al.
Publicado: (2020)

Is it safe to vaccinate rheumatic immunosuppressed patients? Yes, of course, but how?
por: Gillet, Pierre
Publicado: (2021)

Urgent need to address infectious diseases due to immunosuppressive therapies
por: Chastain, Daniel B., et al.
Publicado: (2023)

Special Issue “Cutaneous Lymphomas”
por: Wobser, Marion, et al.
Publicado: (2023)

Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
por: Molina-Molina, Maria
Publicado: (2019)

Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy
por: Darcis, Gilles, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9bs91p78b7co5cdg5tiqegc6l5